Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000479105 | SCV000567920 | uncertain significance | not provided | 2019-07-17 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function |
Ambry Genetics | RCV000575631 | SCV000662373 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-10-17 | criteria provided, single submitter | clinical testing | The p.P38S variant (also known as c.112C>T), located in coding exon 1 of the MSH6 gene, results from a C to T substitution at nucleotide position 112. The proline at codon 38 is replaced by serine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Color Diagnostics, |
RCV000575631 | SCV000908336 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001040637 | SCV001204222 | benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000575631 | SCV002535598 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-04-14 | criteria provided, single submitter | curation |